Gwendolyn M. Hanhart v. Louisiana Cvs Pharmacy LLC; Cvs Pharmacy Inc.; Cvs Health Solutions LLC

CourtLouisiana Court of Appeal
DecidedSeptember 20, 2024
Docket2024-C-0479
StatusPublished

This text of Gwendolyn M. Hanhart v. Louisiana Cvs Pharmacy LLC; Cvs Pharmacy Inc.; Cvs Health Solutions LLC (Gwendolyn M. Hanhart v. Louisiana Cvs Pharmacy LLC; Cvs Pharmacy Inc.; Cvs Health Solutions LLC) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gwendolyn M. Hanhart v. Louisiana Cvs Pharmacy LLC; Cvs Pharmacy Inc.; Cvs Health Solutions LLC, (La. Ct. App. 2024).

Opinion

GWENDOLYN M. HANHART * NO. 2024-C-0479

VERSUS * COURT OF APPEAL LOUISIANA CVS PHARMACY * LLC; CVS PHARMACY INC.; FOURTH CIRCUIT CVS HEALTH SOLUTIONS * LLC STATE OF LOUISIANA *******

APPLICATION FOR WRITS DIRECTED TO FIRST CITY COURT OF NEW ORLEANS NO. 2024-01724, SECTION “A” Honorable Monique G. Morial, Judge ****** Judge Karen K. Herman ****** (Court composed of Judge Sandra Cabrina Jenkins, Judge Paula A. Brown, Judge Tiffany Gautier Chase, Judge Dale N. Atkins, Judge Karen K. Herman)

JENKINS, J., CONCURS IN PART AND DISSENTS IN PART

Karen M. Fontana Young KEAN MILLER LLP 909 Poydras Street, Suite 3600 New Orleans, Louisiana 70112

Jason R. Cashio KEAN MILLER LLP 400 Convention Street, Suite 700 Baton Rouge, Louisiana 70802

COUNSEL FOR DEFENDANTS/RESPONDENTS

Gwendolyn M. Hanhart Attorney at Law, Pro Se 5021 Constance Street New Orleans, Louisiana 70115

WRIT GRANTED; REVERSED AND RENDERED SEPTEMBER 20, 2024 KKH PAB TGC Defendants, Louisiana CVS Pharmacy LLC, CVS Pharmacy, Inc., and CVS DNA Health Solutions LLC (collectively “CVS”) seek supervisory review of the trial

court’s July 22, 2024 judgment denying their exception of no cause of action as to

the claim for intentional infliction of emotional distress (“IIED”) alleged by

plaintiff, Gwendolyn M. Hanhart (“Ms. Hanhart”).1 For the reasons set forth

below, we grant the writ application and reverse.

FACTS AND PROCEDURAL HISTORY

On March 5, 2021, Ms. Hanhart filed a petition for damages alleging that the

actions of CVS personnel, stemming from Ms. Hanhart’s inability to obtain her

prescribed medication in a timely manner, caused her to suffer extreme emotional

distress, accompanied by actual physical suffering.

Ms. Hanhart is prescribed Mounjaro to treat Type 2 diabetes, which she

takes once per week, via an injection on Sundays. Ms. Hanhart acknowledged in

her petition that the medication was not kept in stock, but needed to be ordered.

She received a text on October 8, 2023, from CVS, advising that her prescription

1 The exception of no cause of action was sustained as to Ms. Hanhart’s claims for breach of

contract and Unfair Trade Practices.

1 for Mounjaro 5.0 mg had been filled, but that her primary care physician had

electronically transmitted her new prescription, changing the dosage to 7.5 mg. On

October 8, 2023, Ms. Hanhart contacted her CVS pharmacy via telephone

regarding the dosage discrepancy and she was advised by the pharmacist that he

would cancel the refill for the 5.0 mg. dosage, and fill the new dosage. She was

told that the medication was not in-stock, but would be ordered.

On Saturday, October 14, 2023, Ms. Hanhart called the pharmacy numerous

times to determine the status of the prescription, but was left on hold and was

unable to reach an employee. She arrived at the pharmacy later that night to check

the status of the prescription. At this time, Ms. Hanhart admitted that her own tone

of voice expressed aggravation, irritation and frustration for what she had suffered.

Ms. Hanhart alleged in the petition that the employee rolled her eyes at her, and

“physically and audibly expressed derision to [Ms.] Hanhart.” Ms. Hanhart

asserted that she directed the employee “not to cop an attitude with her.” At that

point, the employee left the register stating that she would not assist Ms. Hanhart.

Ms. Hanhart admitted that both she and the employee engaged in heated verbal

barbs and that the employee made an offensive hand signal toward her. Ms.

Hanhart claimed that no one else at the pharmacy assisted her, although she

informed them that she needed the medication by the next day, and could

experience blood sugar fluctuations without it.

Ms. Hanhart alleged that in addition to the frustration and distress she

suffered at the pharmacy, she also suffered extreme anxiety and nervousness the

rest of Saturday evening, worrying if she would be able to obtain the medication

for her injection due the next day. On Sunday, October 15, 2023, the online status

of the prescription indicated that it was on hold, which again caused her distress.

2 Ms. Hanhart checked another CVS location, but the medication was not readily

available. The following day, on Monday October, 16, 2023, (after what Ms.

Hanhart described as another sleepless night of worry and distress), she was able to

obtain the medication from a nearby Walgreens pharmacy.

Ms. Hanhart alleged that aside from emotional distress, she suffered physical

pain and suffering, including headaches, nausea, and sleeplessness. She further

alleged that CVS knew or should have known of her physical and mental health

conditions - based on her medication history - that Ms. Hanhart experiences mood

and anxiety issues.

CVS filed an exception of no cause of action requesting a dismissal with

prejudice of Ms. Hanhart’s suit in its entirety. As to Ms. Hanhart’s IIED claim,

CVS argued that Ms. Hanhart did not pled facts to satisfy the three required

elements, by establishing: (1) that the conduct of the defendant was extreme and

outrageous; (2) that the emotional distress suffered by the plaintiff was severe; and

(3) that the defendant desired to inflict severe emotional distress or knew that

severe emotional distress would be certain or substantially certain to result from

his or her conduct.

CVS asserted that the alleged conduct did not constitute extreme and

outrageous conduct as required to maintain an IIED claim. CVS further asserted

that Ms. Hanhart admitted to her role in causing a confrontation at the pharmacy,

and that the pharmacy personnel declined to interact with a customer who was

being aggressive. They noted that Ms. Hanhart had not pled that CVS took any

action with the intention of causing severe emotional distress or that anyone at

CVS knew to a reasonable certainty that any of their alleged actions would cause

such distress. Finally, CVS averred that the act that allegedly caused the distress

3 was the failure to fill a prescription by Sunday, October 15, 2023, which Ms.

Hanhart had not claimed was intentionally mishandled.

Exception of No Cause of Action and IIED Claims

Since CVS seeks supervisory review of the denial of their exception of no

cause of action in regard to Ms. Hanhart’s IIED claim, we will discuss the

applicable law relating to both, exceptions of no cause of action and IIED claims.

This Court conducts a de novo review of a trial court’s ruling on an

exception of no cause of action. Kelly v. Jackson, 2023-0285, p. 4 (La. App. 4 Cir.

9/27/23), 373 So.3d 108, 110. The purpose of the exception and the considerations

for its proper determination are as follows:

“The purpose of the peremptory exception of no cause of action is to test the legal sufficiency of the petition by determining whether the law affords a remedy on the facts alleged in the petition.” Scheffler v. Adams & Reese, LLP, 2006-1774, p. 4 (La. 2/22/07), 950 So.2d 641, 646. “When deciding an exception of no cause of action, a court considers only the petition for damages, amendments to the petition for damages and any documents attached to the petition for damages.” Lawrason v. St. Bernard Par. Pub. Sch. Dist., 2022-0319, p. 8 (La. App. 4 Cir. 11/9/22), 351 So.3d 814, 821, writ denied, 2023- 00103 (La. 4/12/23), 359 So.3d 34, reconsideration not considered, 2023-00103 (La. 6/21/23), 362 So.3d 427.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Smith v. State Farm Ins. Companies
869 So. 2d 909 (Louisiana Court of Appeal, 2004)
White v. Monsanto Co.
585 So. 2d 1205 (Supreme Court of Louisiana, 1991)
Everything on Wheels Subaru, Inc. v. Subaru South, Inc.
616 So. 2d 1234 (Supreme Court of Louisiana, 1993)
Scheffler v. Adams and Reese, LLP
950 So. 2d 641 (Supreme Court of Louisiana, 2007)
Sullivan v. Malta Park
156 So. 3d 751 (Louisiana Court of Appeal, 2014)
Reynolds v. Bordelon
172 So. 3d 589 (Supreme Court of Louisiana, 2015)
Green v. Garcia-Victor
248 So. 3d 449 (Louisiana Court of Appeal, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Gwendolyn M. Hanhart v. Louisiana Cvs Pharmacy LLC; Cvs Pharmacy Inc.; Cvs Health Solutions LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gwendolyn-m-hanhart-v-louisiana-cvs-pharmacy-llc-cvs-pharmacy-inc-cvs-lactapp-2024.